Observational Study of Metabolic & Bariatric Surgery in Obesity

This observational study is looking at how metabolic and bariatric surgery affects your body's fat metabolism (how your body processes fats) and certain immune cells called myeloid-derived suppressor cells. Researchers want to understand the connection between these changes after surgery. You may be able to join if you are a biological female between 35 and 60 years old, identify as white or black, have a body mass index (BMI) of 40 or higher, and have high cholesterol (hyperlipidemia). The study will measure changes in fat metabolism and these immune cells at the beginning and again 52 weeks after surgery. The current status of this study is unclear, and it plans to enroll 20 participants.

Study design
This is an observational study, meaning researchers will watch and collect information without assigning treatments. It aims to enroll 20 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for 52 weeks after surgery to measure changes.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06059651

The Effects of Metabolic & Bariatric Surgery on Lipid Metabolism, Myeloid-Derived Suppressor Cells, and Cancer Cell Biology

Recruiting
Not specifiedAges 35–60Observational
Pennington Biomedical Research Center
~20 participants
Updated 2025-02-17 on ClinicalTrials.gov
What's tested:Metabolic & Bariatric Surgery

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in insulin-inhibited adipose tissue lipolysis
Measured over Baseline, week 52
+1 more outcome measured
Obesity
1 sites across 1 states
Louisiana1
  • Justin Brown, Ph.D. · PRINCIPAL_INVESTIGATOR · Pennington Biomedical Research Center

Opens a ready-to-send draft in your own email app — review before sending.

  • Change in insulin-inhibited adipose tissue lipolysisBaseline, week 52
  • Change in the number of circulating myeloid-derived suppressor cellsBaseline, week 52